Laborie Medical Technologies Acquires Pelvalon



Michael T. Holick Michael T. Holick
Sophie A. Staples Sophie A. Staples
M. Z. Lina Pan M. Z. Lina Pan
Jeannine McSweeney Jeannine McSweeney
Alden Millard Alden Millard
+5

The Firm represented Laborie Medical Technologies Inc., a portfolio company of Patricia Industries, in connection with its acquisition of Pelvalon, Inc. Financial details of the transaction were not disclosed. The acquisition closed on October 12, 2021.

Pelvalon, a privately held medical device company, developed the Eclipse System, a non-surgical, patient controlled device for women suffering from fecal incontinence.

Laborie is a leading global developer, manufacturer and marketer of diverse, innovative medical technology used in the diagnosis and treatment of disorders in the urology, gynecology, colorectal and gastrointestinal fields and is also a leader in medical technology developed for labor and delivery and neonatal intensive care.

The Simpson Thacher team included Michael T. Holick, Robert Harrison and Caitlin Locurto (M&A); Sophie Staples, Eli Shalam and Lina Pan (Tax); Jeannine McSweeney, Caitlin Fitzgerald and Brian Chung (Employee Benefits and Executive Compensation); Alden Millard and Kyle Nelson (Credit); Genevieve Dorment, Melanie Jolson and Hilary Wong (Intellectual Property); Vanessa Burrows (Healthcare); Krista McManus (Real Estate); Timothy Mulvihill (Environmental); and David Caldwell (Regulatory).

 

Team and Contacts

Alden Millard

Alden Millard

Chair of the Executive Committee, Partner

Krista B. McManus

Krista B. McManus

Senior Counsel